From Dose Reduction to Contrast Maximization-Reference-Cited by-同舟云学术

From Dose Reduction to Contrast Maximization

Published:2022-04-20 Issue:8 Volume:57 Page:527-535
ISSN:1536-0210
Container-title:Investigative Radiology
language:en
Short-container-title:Invest Radiol

Author:

Bône Alexandre,Ammari Samy,Menu Yves,Balleyguier Corinne,Moulton Eric,Chouzenoux Émilie,Volk Andreas,Garcia Gabriel C.T.E.,Nicolas François,Robert Philippe,Rohé Marc-Michel,Lassau Nathalie

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference35 articles.

1. Glioma;Nat Rev Dis Primers,2015

2. Brain metastases;Nat Rev Dis Primers,2019

3. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study;Lancet Oncol,2019

4. Signal enhancement of the dentate nucleus at unenhanced MR imaging after very high cumulative doses of the macrocyclic gadolinium-based contrast agent gadobutrol: an observational study;Radiology,2017

5. Gadolinium-based contrast agent accumulation and toxicity: an update;AJNR Am J Neuroradiol,2016

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial T1-Weighted Postcontrast Brain MRI;Investigative Radiology;2024-07-30

2. MRI Gadolinium‐Based Contrast Media: Meeting Radiological, Clinical, and Environmental Needs;Journal of Magnetic Resonance Imaging;2024-01-16

3. Reducing Gadolinium Contrast With Artificial Intelligence;Journal of Magnetic Resonance Imaging;2023-10-31

4. A New Era in Magnetic Resonance Contrast Media;Investigative Radiology;2023-10-20

5. Clinical Efficacy of Gadobutrol: Review of Over 25 Years of Use Exceeding 100 Million Administrations;Investigative Radiology;2023-10-18